Latest & greatest articles for mammography

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on mammography or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on mammography and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for mammography

61. Effect of mammography screening on surgical treatment for breast cancer in Norway: comparative analysis of cancer registry data.

Effect of mammography screening on surgical treatment for breast cancer in Norway: comparative analysis of cancer registry data. OBJECTIVE: To determine the effect of mammography screening on surgical treatment for breast cancer. DESIGN: Comparative analysis of data from Norwegian cancer registry. SETTING: Mammography screening, Norway (screening of women aged 50-69 was introduced sequentially from 1996 to 2004). PARTICIPANTS: 35,408 women aged 40-79 with invasive breast cancer or ductal (...) was 31% (1.31, 1.20 to 1.43) higher in the invited than in the non-invited younger age group. CONCLUSIONS: Mammography screening in Norway was associated with a noticeable increase in rates for breast cancer surgery in women aged 50-69 (the age group invited to screening) and also an increase in mastectomy rates. Although over-diagnosis is likely to have caused the initial increase in mastectomy rates and the overall increase in surgery rates in the age group screened, the more recent decline

BMJ2011 Full Text: Link to full Text with Trip Pro

62. Personalizing mammography by breast density and other risk factors for breast cancer: analysis of health benefits and cost-effectiveness.

Personalizing mammography by breast density and other risk factors for breast cancer: analysis of health benefits and cost-effectiveness. BACKGROUND: Current guidelines recommend mammography every 1 or 2 years starting at age 40 or 50 years, regardless of individual risk for breast cancer. OBJECTIVE: To estimate the cost-effectiveness of mammography by age, breast density, history of breast biopsy, family history of breast cancer, and screening interval. DESIGN: Markov microsimulation model (...) . DATA SOURCES: Surveillance, Epidemiology, and End Results program, Breast Cancer Surveillance Consortium, and the medical literature. TARGET POPULATION: U.S. women aged 40 to 49, 50 to 59, 60 to 69, and 70 to 79 years with initial mammography at age 40 years and breast density of Breast Imaging Reporting and Data System (BI-RADS) categories 1 to 4. TIME HORIZON: Lifetime. PERSPECTIVE: National health payer. INTERVENTION: Mammography annually, biennially, or every 3 to 4 years or no mammography

Annals of Internal Medicine2011 Full Text: Link to full Text with Trip Pro

63. Full-field digital mammography for breast cancer screening

Full-field digital mammography for breast cancer screening Full-field digital mammography for breast cancer screening Full-field digital mammography for breast cancer screening Record Status This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has been made for the HTA database. Citation Full-field digital mammography for breast cancer screening. Lansdale: HAYES, Inc.. Directory Publication. 2011 Authors' objectives Full (...) -field digital mammography (FFDM) is an alternative to conventional screen-film mammography (SFM), the standard of care for detecting breast cancer. With digital mammography, images of the breast are acquired, displayed, transferred, and stored as digital data for viewing on a computer monitor (soft-copy reading) or for printing and viewing with a light box (hard-copy reading). In contrast to SFM, FFDM simplifies image interpretation because image acquisition, image processing, image review, and data

Health Technology Assessment (HTA) Database.2011

64. Accuracy and outcomes of screening mammography in women with a personal history of early-stage breast cancer.

Accuracy and outcomes of screening mammography in women with a personal history of early-stage breast cancer. CONTEXT: Women with a personal history of breast cancer (PHBC) are at risk of developing another breast cancer and are recommended for screening mammography. Few high-quality data exist on screening performance in PHBC women. OBJECTIVE: To examine the accuracy and outcomes of mammography screening in PHBC women relative to screening of similar women without PHBC. DESIGN AND SETTING (...) : Cohort of PHBC women, mammogram matched to non-PHBC women, screened through facilities (1996-2007) affiliated with the Breast Cancer Surveillance Consortium. PARTICIPANTS: There were 58,870 screening mammograms in 19,078 women with a history of early-stage (in situ or stage I-II invasive) breast cancer and 58,870 matched (breast density, age group, mammography year, and registry) screening mammograms in 55,315 non-PHBC women. MAIN OUTCOME MEASURES: Mammography accuracy based on final assessment

JAMA2011 Full Text: Link to full Text with Trip Pro

65. Comparative evaluation of digital mammography and film mammography: systematic review and meta-analysis

Comparative evaluation of digital mammography and film mammography: systematic review and meta-analysis Comparative evaluation of digital mammography and film mammography: systematic review and meta-analysis Comparative evaluation of digital mammography and film mammography: systematic review and meta-analysis Iared W, Shigueoka DC, Torloni MR, Velloni FG, Ajzen SA, Atallah AN, Valente O CRD summary This review concluded that cancer detection rates were slightly higher using digital mammography (...) than film mammography. Characteristics of tumours detected were similar and there were no significant differences in recall rates between film and digital mammography. These conclusions reflect the data, but should be interpreted cautiously, given limitations in the review process and analysis and small effect sizes. Authors' objectives To compare the performance of digital and film mammography for breast cancer screening. Searching MEDLINE, Scopus, EMBASE and LILACS were searched to September 2009

DARE.2011

66. Surveillance mammography for detecting ipsilateral breast tumour recurrence and metachronous contralateral breast cancer: a systematic review

Surveillance mammography for detecting ipsilateral breast tumour recurrence and metachronous contralateral breast cancer: a systematic review Surveillance mammography for detecting ipsilateral breast tumour recurrence and metachronous contralateral breast cancer: a systematic review Surveillance mammography for detecting ipsilateral breast tumour recurrence and metachronous contralateral breast cancer: a systematic review Robertson C, Arcot Ragupathy SK, Boachie C, Fraser C, Heys SD, MacLennan (...) G, Mowatt G, Thomas RE, Gilbert FJ, Mammographic Surveillance Health Technology Assessment Group CRD summary This review concluded that magnetic resonance imaging was better than surveillance mammography in diagnosing ipsilateral breast tumour recurrence and new contralateral breast cancer in women previously treated for primary breast cancer. This conclusion reflected the limited data available, but limitations in the search and study selection process might have resulted in relevant studies

DARE.2011

67. Effectiveness of mammography screening in reducing breast cancer mortality in women aged 39-49 years: a meta-analysis

Effectiveness of mammography screening in reducing breast cancer mortality in women aged 39-49 years: a meta-analysis Effectiveness of mammography screening in reducing breast cancer mortality in women aged 39-49 years: a meta-analysis Effectiveness of mammography screening in reducing breast cancer mortality in women aged 39-49 years: a meta-analysis Magnus MC, Ping M, Shen MM, Bourgeois J, Magnus JH CRD summary This review concluded that mammography screenings were effective and reduced (...) breast cancer mortality in women aged 39 to 49 by 17%. This represented a reduction from a very low absolute risk; the authors further concluded that women should be clearly informed of both positive and negative aspects of screening. The conclusion as a whole is likely to be reliable. Authors' objectives To evaluate the effectiveness of mammography screening in women aged 39 to 49 years for the reduction of breast cancer mortality. Searching MEDLINE, The Cochrane Library and ERIC were searched up

DARE.2011

68. The Efficacy of Breast Specific Gamma Imaging Over Mammography for Breast Cancer Screening in All Women.

The Efficacy of Breast Specific Gamma Imaging Over Mammography for Breast Cancer Screening in All Women. "The Efficacy of Breast Specific Gamma Imaging Over Mammography for Bre" by Tawny Schmeer < > > > > > Title Author Date of Award Winter 1-2011 Degree Type Capstone Project Degree Name Master of Science in Physician Assistant Studies First Advisor Dr. Torry Cobb Rights . Abstract Background: As the second most diagnosed cancer among women in the US, breast cancer has been, and continues (...) to be, a life threatening disease affecting thousands. Mammography has been the primary tool used in screening for breast cancer for decades, despite minimal advancement in the area of its main limitation, dense breast tissue. Recently gamma imaging has undergone significant improvements in the area of breast specific imaging and appears primed to address the needs of a population where mammography is insufficient. The purpose of this systematic review is to compare the efficacy of Breast Specific Gamma

Pacific University EBM Capstone Project2011

70. Screening mammography - a long run for a short slide?

Screening mammography - a long run for a short slide? Screening mammography--a long run for a short slide? - PubMed - NCBI Warning: The NCBI web site requires JavaScript to function. Search database Search term Search Result Filters Format Summary Summary (text) Abstract Abstract (text) MEDLINE XML PMID List Apply Choose Destination File Clipboard Collections E-mail Order My Bibliography Citation manager Format Create File 1 selected item: 20860510 Format MeSH and Other Data E-mail Subject (...) Additional text E-mail Add to Clipboard Add to Collections Order articles Add to My Bibliography Generate a file for use with external citation management software. Create File 2010 Sep 23;363(13):1276-8. doi: 10.1056/NEJMe1008369. Screening mammography--a long run for a short slide? . Comment in [N Engl J Med. 2011] Comment on [N Engl J Med. 2010] PMID: 20860510 DOI: [Indexed for MEDLINE] Publication types MeSH terms Full Text Sources Medical PubMed Commons 0 comments How to cite this comment

NEJM2010

71. Effect of screening mammography on breast-cancer mortality in Norway.

Effect of screening mammography on breast-cancer mortality in Norway. BACKGROUND: A challenge in quantifying the effect of screening mammography on breast-cancer mortality is to provide valid comparison groups. The use of historical control subjects does not take into account chronologic trends associated with advances in breast-cancer awareness and treatment. METHODS: The Norwegian breast-cancer screening program was started in 1996 and expanded geographically during the subsequent 9 years (...) . Women between the ages of 50 and 69 years were offered screening mammography every 2 years. We compared the incidence-based rates of death from breast cancer in four groups: two groups of women who from 1996 through 2005 were living in counties with screening (screening group) or without screening (nonscreening group); and two historical-comparison groups that from 1986 through 1995 mirrored the current groups. RESULTS: We analyzed data from 40,075 women with breast cancer. The rate of death

NEJM2010

72. Breast cancer mortality in organised mammography screening in Denmark: comparative study.

Breast cancer mortality in organised mammography screening in Denmark: comparative study. OBJECTIVE: To determine whether the previously observed 25% reduction in breast cancer mortality in Copenhagen following the introduction of mammography screening was indeed due to screening, by using an additional screening region and five years additional follow-up. DESIGN: We used Poisson regression analyses adjusted for changes in age distribution to compare the annual percentage change in breast (...) cancer mortality in areas where screening was used with the change in areas where it was not used during 10 years before screening was introduced and for 10 years after screening was in practice (starting five years after introduction of screening). SETTING: Copenhagen, where mammography screening started in 1991, and Funen county, where screening was introduced in 1993. The rest of Denmark (about 80% of the population) served as an unscreened control group. PARTICIPANTS: All Danish women recorded

BMJ2010 Full Text: Link to full Text with Trip Pro

73. Interventions to promote repeat breast cancer screening with mammography: a systematic review and meta-analysis

Interventions to promote repeat breast cancer screening with mammography: a systematic review and meta-analysis Interventions to promote repeat breast cancer screening with mammography: a systematic review and meta-analysis Interventions to promote repeat breast cancer screening with mammography: a systematic review and meta-analysis Vernon SW, McQueen A, Tiro JA, del Junco DJ CRD summary Reminder-only interventions and more intensive strategies of education/motivation or counselling (...) significantly promoted repeat mammography screening for breast cancer. The high level of heterogeneity found for reminder-only studies precluded the conclusion that they were more effective than alternative strategies. Potential limitations to the review process and uncertain study quality make the reliability of the authors’ conclusions unclear. Authors' objectives To evaluate the efficacy of interventions, particularly reminder-only interventions, to promote repeat breast cancer screening with mammography

DARE.2010

74. Randomised controlled trial: A web-based tailored educational intervention increases positive perceptions of mammography and intention to obtain mammography compared to standardised mammography brochures among Taiwanese women

Randomised controlled trial: A web-based tailored educational intervention increases positive perceptions of mammography and intention to obtain mammography compared to standardised mammography brochures among Taiwanese women A web-based tailored educational intervention increases positive perceptions of mammography and intention to obtain mammography compared to standardised mammography brochures among Taiwanese women | Evidence-Based Nursing This site uses cookies. By continuing to browse (...) intervention increases positive perceptions of mammography and intention to obtain mammography compared to standardised mammography brochures among Taiwanese women Article Text Therapeutics Randomised controlled trial A web-based tailored educational intervention increases positive perceptions of mammography and intention to obtain mammography compared to standardised mammography brochures among Taiwanese women Maggi Banning Statistics from Altmetric.com No Altmetric data available for this article

Evidence-Based Nursing (Requires free registration)2010

75. Cost-effectiveness of breast MR imaging and screen-film mammography for screening BRCA1 gene mutation carriers

Cost-effectiveness of breast MR imaging and screen-film mammography for screening BRCA1 gene mutation carriers Cost-effectiveness of breast MR imaging and screen-film mammography for screening BRCA1 gene mutation carriers Cost-effectiveness of breast MR imaging and screen-film mammography for screening BRCA1 gene mutation carriers Lee JM, McMahon PM, Kong CY, Kopans DB, Ryan PD, Ozanne EM, Halpern EF, Gazelle GS Record Status This is a critical abstract of an economic evaluation that meets (...) the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. CRD summary This study examined the cost-effectiveness of screening for breast cancer, using magnetic resonance imaging (MRI), screen-film mammography, or both, for women with mutations of the breast cancer gene BRCA1. The authors concluded that annual mammography and MRI detected

NHS Economic Evaluation Database.2010

76. Breaking News: Initiate Mammography Screening at 50, not 40, Says USPSTF.

Breaking News: Initiate Mammography Screening at 50, not 40, Says USPSTF. Breaking News: Initiate Mammography Screening at 50, not 40, Says USPSTF. | Clinical Correlations Breaking News: Initiate Mammography Screening at 50, not 40, Says USPSTF. November 17, 2009 Aalok Turakhia, MD As the debate over when to begin screening mammography in women rages on, the United States Prevention Service Task Force (USPSTF) added fuel to the fire by releasing a new recommendation statement in the November (...) 17th issue of the Annals of Internal Medicine. Applying to women aged ≥40 who are not at an increased genetic risk or have had chest irradiation, the USPSTF now recommends biennial screening in women between ages 50-74. In February 2002, the task force first recommended that annual or biennial screening start at age 40; however, in a revised statement, “The USPSTF recommends against routine screening mammography in women aged 40 to 49 years.” It adds, “The decision to start regular, biennial

Clinical Correlations2009

77. Effects of Mammography Screening Under Different Screening Schedules: Model Estimates of Potential Benefits and Harms.

Effects of Mammography Screening Under Different Screening Schedules: Model Estimates of Potential Benefits and Harms. BACKGROUND: Despite trials of mammography and widespread use, optimal screening policy is controversial. OBJECTIVE: To evaluate U.S. breast cancer screening strategies. DESIGN: 6 models using common data elements. DATA SOURCES: National data on age-specific incidence, competing mortality, mammography characteristics, and treatment effects. TARGET POPULATION: A contemporary

Annals of Internal Medicine2009 Full Text: Link to full Text with Trip Pro

78. A meta-analysis of interventions to promote mammography among ethnic minority women

A meta-analysis of interventions to promote mammography among ethnic minority women 19609176 2009 07 17 2009 08 11 2016 11 22 1538-9847 58 4 2009 Jul-Aug Nursing research Nurs Res A meta-analysis of interventions to promote mammography among ethnic minority women. 246-54 10.1097/NNR.0b013e3181ac0f7f Although many studies have been focused on interventions designed to promote mammography screening among ethnic minority women, few summaries of the effectiveness of the interventions are available (...) . The aim of this study was to determine the effectiveness of the interventions for improving mammography screening among asymptomatic ethnic minority women. A meta-analysis was performed on intervention studies designed to promote mammography use in samples of ethnic minority women. Random-effects estimates were calculated for interventions by measuring differences in intervention and control group screening rates postintervention. The overall mean weighted effect size for the 23 studies was 0.078 (Z

EvidenceUpdates2009 Full Text: Link to full Text with Trip Pro

79. Full-field digital versus screen-film mammography: comparison within the UK breast screening program and systematic review of published data

Full-field digital versus screen-film mammography: comparison within the UK breast screening program and systematic review of published data 19401569 2009 04 29 2009 05 28 2016 11 25 1527-1315 251 2 2009 May Radiology Radiology Full-field digital versus screen-film mammography: comparison within the UK breast screening program and systematic review of published data. 347-58 10.1148/radiol.2512081235 To (a) compare the performance of full-field digital mammography (FFDM), using hard-copy image (...) reading, with that of screen-film mammography (SFM) within a UK screening program (screening once every 3 years) for women aged 50 years or older and (b) conduct a meta-analysis of published findings along with the UK data. The study complied with the UK National Health Service Central Office for Research Ethics Committee guidelines; informed patient consent was not required, since analysis was carried out retrospectively after data anonymization. Between January 2006 and June 2007, a London

EvidenceUpdates2009

80. Cost-effectiveness analysis of mammography and clinical breast examination strategies: a comparison with current guidelines

Cost-effectiveness analysis of mammography and clinical breast examination strategies: a comparison with current guidelines Cost-effectiveness analysis of mammography and clinical breast examination strategies: a comparison with current guidelines Cost-effectiveness analysis of mammography and clinical breast examination strategies: a comparison with current guidelines Ahern CH, Shen Y Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion (...) on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. CRD summary The aim was to assess the cost-effectiveness of breast cancer screening strategies that combined mammography and clinical breast examination. The authors suggested that, due to its superior cost-effectiveness, the strategy of mammography and clinical breast examination every two years, and given

NHS Economic Evaluation Database.2009